| 1 |
20194144 | Treatment considerations for patients with neuropathic pain and other medical comorbidities. | 2010 Mar |
1 |
| 2 |
20441720 | Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder. | 2010 Nov |
2 |
| 3 |
19142106 | Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. | 2009 Feb |
1 |
| 4 |
18840027 | Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects. | 2008 |
1 |
| 5 |
17803873 | Cytochrome P450 2D6 genotype variation and venlafaxine dosage. | 2007 Sep |
1 |
| 6 |
9165554 | Venlafaxine and nefazodone, two pharmacologically distinct antidepressants. | 1997 May-Jun |
1 |